Every material Form 8-K Abercrombie & Fitch filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Abercrombie & Fitch reported second-quarter fiscal 2026 net sales of $1.3 billion, up 5% from a year earlier, and diluted EPS of $4.17 versus $2.91 a year ago. The quarter includes about $100 million of IEEPA tariff refunds, worth $1.75 per diluted share, and the company raised its full-year EPS outlook to $13.10 to $13.60 from $10.20 to $11.00.
Q2 net sales $1.3 billion, up 5%; comparable sales flat
Operating margin 19.9% vs 17.1% a year ago; includes about $100 million tariff refund benefit
Full-year EPS outlook raised to $13.10 to $13.60; share repurchases at least $500 million vs around $450 million previously
Q3 outlook: net sales growth 5% to 6%, EPS $2.90 to $3.20
Abercrombie & Fitch expanded its Board from nine to 10 members on August 18, 2026, and appointed Mary Fox as a non-associate director. Fox is currently president of The Lovesac Company, and her term runs until the 2027 Annual Meeting. The filing does not yet name her Board committee assignments, which the company says it will disclose later.
Board increased from nine to 10 members; Fox appointed effective August 18, 2026
Fox, 54, is President of The Lovesac Company; previously held roles at BIC, L'Oréal and Walmart
Fox's pay follows the non-associate director program described in the April 20, 2026 proxy statement, pro-rated to the 2027 Annual Meeting
Board committee assignments not yet determined; company intends to file an amendment
Abercrombie & Fitch reported first-quarter fiscal 2026 net sales of $1.1 billion, up 2% from last year, with comparable sales down 1%. Diluted earnings per share fell to $1.47 from $1.59, and operating margin fell to 8.0% from 9.3%, though the company said EPS exceeded its outlook range. The company kept its full-year outlook unchanged, which matters to shareholders because it signals no change to its earnings or sales targets despite weaker EMEA demand.
Net sales of $1.1 billion, up 2%; comparable sales down 1%; EMEA sales down 10%, APAC up 24%
Diluted EPS of $1.47 vs. $1.59 a year earlier; operating margin of 8.0% vs. 9.3%
Full-year outlook maintained: net sales growth of 3% to 5%, diluted EPS of $10.20 to $11.00, share repurchases of around $450 million
Repurchased $105 million of shares in the quarter, with $745 million remaining on the March 2025 authorization
Abercrombie & Fitch reported unaudited results for the fourth quarter and fiscal year ended January 31, 2026. Fourth-quarter net sales rose 5% to $1.67 billion and diluted EPS rose to $3.68 from $3.57, while operating margin fell to 14.1% from 16.2%. For the full year, net sales rose 6% to $5.27 billion, but diluted EPS fell to $10.46 from $10.69, or $9.86 excluding a one-time litigation settlement gain, and the company guided fiscal 2026 EPS to $10.20 to $11.00.
Q4 net sales $1.67 billion, up 5%; comparable sales up 1%; operating income $236 million vs. $256 million a year earlier
Full-year net sales $5.27 billion, up 6%; GAAP diluted EPS $10.46 and adjusted $9.86, vs. $10.69 in fiscal 2024
Full-year operating margin 13.3% reported and 12.5% adjusted, vs. 15.0% a year earlier
Fiscal 2026 outlook: net sales growth 3% to 5%, operating margin 12.0% to 12.5%, EPS $10.20 to $11.00, including a 15% tariff assumption
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Abercrombie & Fitch filing is on SEC EDGAR ↗. 8-K briefs of other companies →